The Future of Cancer Research
From Freethink Health
Creativity & AI
Intel employee Bryce Olson was diagnosed with stage 4 prostate cancer. When the standard of care didn’t work, Bryce turned to genomic sequencing which allowed his doctors to identify specific genetic drivers of his disease and specific treatments and clinical trials that were a fit for his cancer. This precision medicine approach helped send his cancer into remission for several years.
Now that his cancer has returned, Bryce is working with the Broad Institute and other leaders in the field of advanced cancer research to use artificial intelligence powered by Intel technology to discover new, innovative solutions that can help him and millions of others like him around the world.
Since the invention of early automation machines, humans have grappled with the challenge of how to work alongside machines and how to think about the displacement of specialty that often follows their invention. With AI’s expansion into creative fields, questions arise about the uniqueness of human creativity and whether AI is a tool, a rival, or a new collaborator. In this special issue, we set out to explore perspectives from technologists, artists, and experts to understand the comprehensive implications of AI-driven creativity on our future.
Freethink Media, a digital publisher telling stories about the people and ideas moving our world forward to over 20+ million followers, recently released a special issue: Creativity & AI. Each week we will highlight here one of Freethink’s compelling articles or docu-style videos that delves into the influence of AI and its profound impact on our world and society today. Known for captivating content featuring news from the frontiers, Freethink is committed to being a trusted source for exploring the transformative power of AI.